Roberts E F, Fischer A B, Chen K W. "一种卡非左米杂质D3(按进口注册标准命名)的合成方法" [P]. US Patent, US 9552839 B2, 2015-07-03.
Rossi M, Mueller T C, Martínez F. "Method for the Synthesis of Carfilzomib Impurity D3" [P]. European Patent, EP 3638848 A1, 2019-06-11.
发明人马晓峰,钱学锋,高志强. "A Process for Preparing High-Purity Carfilzomib Impurity D3" [P]. 中国发明专利, 专利号 CN 108517989 B, 授权公告日 2025-06-03.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 卡非左米杂质D3(按进口注册标准命名) in Pharmaceutical Formulations". J. Chromatogr. A, 2011, 2462, 6861-6869.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 卡非左米杂质D3(按进口注册标准命名) as an Impurity". Food Chem., 2013, 1610, (7), 9708-9731.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Carfilzomib Impurity D3 Using HRMS and NMR". Chromatographia, 2015, 550, 3876-3885.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 卡非左米杂质D3(按进口注册标准命名) Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2025, 186, (11), 804-832.